Mechanism of New Antipsychotic Medications
- 1 October 2003
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 60 (10) , 974-977
- https://doi.org/10.1001/archpsyc.60.10.974
Abstract
Opinion from JAMA Psychiatry — Mechanism of New Antipsychotic Medications — Occupancy Is Not Just AntagonismKeywords
This publication has 32 references indexed in Scilit:
- Atypical antipsychotic drug actions: unitary or multiple mechanisms for ‘atypicality’?Clinical Neuroscience Research, 2003
- Efficacy and Safety of Aripiprazole and Haloperidol Versus Placebo in Patients With Schizophrenia and Schizoaffective DisorderThe Journal of Clinical Psychiatry, 2002
- Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode SchizophreniaAmerican Journal of Psychiatry, 2000
- Clinical and Theoretical Implications of 5-HT2 and D2 Receptor Occupancy of Clozapine, Risperidone, and Olanzapine in SchizophreniaAmerican Journal of Psychiatry, 1999
- 5-HT2 and D2 Receptor Occupancy of Olanzapine in Schizophrenia: A PET InvestigationAmerican Journal of Psychiatry, 1998
- A new framework for investigating antipsychotic action in humans: lessons from PET imaging.Molecular Psychiatry, 1998
- Extrapyramidal side effects with risperidone and haloperidol at comparable D2 receptor occupancy levelsPsychiatry Research: Neuroimaging, 1997
- Time Course of 5-HT2A Receptor Occupancy in the Human Brain after a Single Oral Dose of the Putative Antipsychotic Drug MDL 100,907 Measured by Positron Emission TomographyNeuropsychopharmacology, 1997
- Positron Emission Tomography Studies on D2 and 5-HT2 Receptor Binding in Risperidone-Treated Schizophrenic PatientsJournal of Clinical Psychopharmacology, 1995
- Central D2-Dopamine Receptor Occupancy in Schizophrenic Patients Treated With Antipsychotic DrugsArchives of General Psychiatry, 1988